A detailed history of Wealth Advisors Of Iowa, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wealth Advisors Of Iowa, LLC holds 5,112 shares of BMY stock, worth $264,546. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,112
Previous 6,312 19.01%
Holding current value
$264,546
Previous $342,000 38.01%
% of portfolio
0.01%
Previous 0.21%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $48,300 - $63,588
-1,200 Reduced 19.01%
5,112 $212,000
Q1 2024

May 07, 2024

SELL
$47.98 - $54.4 $25,189 - $28,560
-525 Reduced 7.68%
6,312 $342,000
Q4 2023

Feb 08, 2024

BUY
$48.48 - $57.85 $2,036 - $2,429
42 Added 0.62%
6,837 $350,000
Q3 2023

Nov 07, 2023

BUY
$57.89 - $64.73 $2,026 - $2,265
35 Added 0.52%
6,795 $394,000
Q2 2023

Jul 25, 2023

BUY
$63.71 - $70.74 $1,975 - $2,192
31 Added 0.46%
6,760 $432,000
Q1 2023

May 09, 2023

SELL
$65.71 - $74.53 $37,454 - $42,482
-570 Reduced 7.81%
6,729 $466,000
Q4 2022

Feb 10, 2023

BUY
$68.48 - $81.09 $42,868 - $50,762
626 Added 9.38%
7,299 $525,000
Q3 2022

Nov 15, 2022

BUY
$0.13 - $76.84 $177 - $105,040
1,367 Added 25.76%
6,673 $475,000
Q2 2022

Jul 28, 2022

BUY
$72.62 - $79.98 $6,608 - $7,278
91 Added 1.74%
5,306 $409,000
Q1 2022

May 10, 2022

BUY
$61.48 - $73.72 $102,610 - $123,038
1,669 Added 47.07%
5,215 $381,000
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $87,256 - $101,720
-1,627 Reduced 31.45%
3,546 $221,000
Q3 2021

Nov 09, 2021

BUY
$59.17 - $69.31 $946 - $1,108
16 Added 0.31%
5,173 $306,000
Q2 2021

Jul 26, 2021

BUY
$61.91 - $67.42 $1,052 - $1,146
17 Added 0.33%
5,157 $345,000
Q1 2021

Apr 29, 2021

BUY
$59.34 - $66.74 $1,068 - $1,201
18 Added 0.35%
5,140 $324,000
Q1 2020

Apr 28, 2020

BUY
$46.4 - $67.43 $237,660 - $345,376
5,122 New
5,122 $286,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $110B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Wealth Advisors Of Iowa, LLC Portfolio

Follow Wealth Advisors Of Iowa, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Advisors Of Iowa, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Advisors Of Iowa, LLC with notifications on news.